Clinical Trial Update: Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the safety, efficacy, and PK/PD of QGE031 versus placebo in patients with active bullous pemphigoid on oral steroids. The study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• QGE031

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Bullous Pemphigoid | Phase 2 | Status: TERMINATED | Results posted: 2016-04-28